Dr. Oded Langer, Obstetrician and Gynecologist, Professor at Columbia University, explains that he always tries to follow-up with his GDM patients for the development of type 2 and between 50-80% of them eventually develop the disease. He also stresses the importance of this follow-up for the infant, and that good prevention strategies …

Dr. Langer explains why HbA1c is not a good a test for pregnant women because of the natural changes in a pregnant woman’s blood cells as well as the limited time of the pregnancy (as compared to measuring HbA1c over longer periods of time in a non-pregnant person). He discusses …

Dr. Langer discusses the difficult challenges of researching and introducing new diabetes drugs for pregnant women with either GDM or type 2, including how to determine if a drug can cross the placenta from mother to fetus (giving us some examples), and the importance of monitoring children for potential long-term …

Dr. Oded Langer, Obstetrician and Gynecologist, Professor at Columbia University, gives us an overview on the paper he presented at AACE, the specific drugs — metformin and glyburide — which his team has researched, and some of the results of his studies. More videos with Dr. Langer: Oded Langer, MD, PhD, Introduction …

Dr. Langer introduces himself and what he is working on currently. More videos with Dr. Langer: Pregnancy and the Safety of Oral Diabetes Medications  What Diabetes Drugs Can Be Used by Pregnant Women with Diabetes?  What Is the Best Test for Blood Glucose Levels in Diabetic Women? Do Many of …